Price to Sales multipleMicrobix is way undervalued based on the average price to sales multiple for the industry. With annualized sales of $9.3 million and a current market cap of $19.5 million, the price to sales multiple given is only 2.1. That is well below the 7.74 suggested on the following site for a company in the bio tech industry. https://pages.stern.nyu.edu/~adamodar/New_Home_Page/datafile/psdata.html If we ever got close to that figure, we would be trading at $0.80. Another reason why the current share price has to be close or near to the bottom that it should ever get to base don current sales and trend.